COVID trials halted for hydroxychloroquine after failure to reduce death
Saturday, 4 July 2020 ()
WHO said the decision to halt the trials does not affect other studies where the drugs are used for non-hospitalized patients or as a prophylaxis.
COVID trials halted for hydroxychloroquine after failure to reduce death
Saturday, 4 July 2020 ()
WHO said the decision to halt the trials does not affect other studies where the drugs are used for non-hospitalized patients or as a prophylaxis. |
|
|||